ACTRN12616000843459已完成未知
Weight gain and appetite changes following treatment for thyrotoxicosis – a pilot study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients presenting with overt thyrotoxicosis
- •Able to consent
- •For controls - normal thyroid function, able to consent, being assessed in thyroid clinic for structural thyroid disease e.g. nodule
排除标准
- •Unable to consent
- •Subclinical thyrotoxicosis
- •Current pregnancy or pregnancy within the past 6 months
- •These exclusions are the same for both participants and controls
研究者
相似试验
已完成
不适用
Susceptibility to Weight Gain: Studies of Appetite Regulation in Lean, Overweight & Obese Men & WomeACTRN12611000294954The University of Auckland100
进行中（未招募）
不适用
Weight gain, eating patterns, and development of body composition during initiation of basal insulin therapy: a comparison of insulin detemir and insulin glargineEUCTR2007-000353-65-ATniversity Hospital Tübingen160
已完成
不适用
Investigation of dietary changes before and after utilizing a postal inspectioJPRN-UMIN000046762Healthcare Systems Co., Ltd.300
进行中（未招募）
不适用
Weight gain, eating patterns and development of body composition during initiation of basal insulin therapy: a comparison of insulin determir and insulin glargineTyp 2 diabetesMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-000353-65-DEniversity Hospital Tübingen160
进行中（未招募）
1 期
The effects of the fatty acids arachidonic acid (ARA) and docosahexaenoic acid (DHA) on growth, metabolism and inflammatory response in infants born extremely pretermTo determine whether early and prolonged supply of ARA and DHA improves quality of growth and clinical outcomes in extreme premature infants as compared to our present nutrient supply. By closely assessing nutritional intake, anthropometric measures, clinical outcomes and several biomarkers of inflammation and metabolism, we hope to elucidate mechanisms of inflammation and metabolic mediated damage to major organs such as brain, lung, eye and cardiovascular system of extremely premature infants.EUCTR2016-003700-31-NOOslo University Hospital120